Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study
The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). The baseline data of 5511 subject...
Saved in:
Published in | Journal of diabetes and its complications Vol. 30; no. 2; pp. 269 - 274 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2016
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 1056-8727 1873-460X 1873-460X |
DOI | 10.1016/j.jdiacomp.2015.11.019 |
Cover
Abstract | The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).
The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.
The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.
Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. |
---|---|
AbstractList | The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).
The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.
The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.
Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. Abstract Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged ≥ 18 years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity = 64.4%, specificity = 66.8%] and 1.79 [sensitivity = 66.2%, specificity = 62.2%] in men and were 2.5 [sensitivity = 57.6%, specificity = 67.9%] and 1.95 [sensitivity = 65.1%, specificity = 54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity = 63.7%, specificity = 67.8%] and 0.347 [sensitivity = 62.9%, specificity = 65.0%] in men and were 0.331 [sensitivity = 55.7%, specificity = 70.7%] and 0.333 [sensitivity = 53.2%, specificity = 67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).AIMSThe present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).The baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.METHODSThe baseline data of 5511 subjects aged ≥18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD.The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.RESULTSThe optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively.Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions.CONCLUSIONNot only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged >=18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) in the diagnosis of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD). Methods The baseline data of 5511 subjects aged greater than or equal to 18years of a cohort study in northern Iran were utilized to analyze. Receiver operating characteristic (ROC) analysis was conducted to determine the discriminatory capability of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Youden index was utilized to determine the optimal cutoff points of HOMA-IR and QUICKI in the diagnosis of MetS and NAFLD. Results The optimal cutoff points for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 [sensitivity=64.4%, specificity=66.8%] and 1.79 [sensitivity=66.2%, specificity=62.2%] in men and were 2.5 [sensitivity=57.6%, specificity=67.9%] and 1.95 [sensitivity=65.1%, specificity=54.7%] in women respectively. Furthermore, the optimal cutoff points for QUICKI in the diagnosis of MetS and NAFLD were 0.343 [sensitivity=63.7%, specificity=67.8%] and 0.347 [sensitivity=62.9%, specificity=65.0%] in men and were 0.331 [sensitivity=55.7%, specificity=70.7%] and 0.333 [sensitivity=53.2%, specificity=67.7%] in women respectively. Conclusion Not only the optimal cutoff points of HOMA-IR and QUICKI were different for MetS and NAFLD, but also different cutoff points were obtained for men and women for each of these two conditions. |
Author | Maadi, Mansooreh Miresmail, Seyed Javad Haji Farahani, Behzad Motamed, Nima Zamani, Farhad Rabiee, Behnam Keyvani, Hossein |
Author_xml | – sequence: 1 givenname: Nima surname: Motamed fullname: Motamed, Nima organization: Department of Social Medicine, Zanjan University of Medical Sciences, Gavazang Road, Zanjan, Iran – sequence: 2 givenname: Seyed Javad Haji surname: Miresmail fullname: Miresmail, Seyed Javad Haji organization: Department of Cardiology, Hazrat Rasoul Hospital, Iran University of Medical Sciences, Niayesh St. Satarkhan Ave., 1445613131, Tehran, Iran – sequence: 3 givenname: Behnam surname: Rabiee fullname: Rabiee, Behnam organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran – sequence: 4 givenname: Hossein surname: Keyvani fullname: Keyvani, Hossein organization: Department of Virology, Tehran University of Medical Sciences, Poursina St, 16 Azar Ave, Keshavarz BLVD, Tehran, Iran – sequence: 5 givenname: Behzad surname: Farahani fullname: Farahani, Behzad organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran – sequence: 6 givenname: Mansooreh surname: Maadi fullname: Maadi, Mansooreh organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran – sequence: 7 givenname: Farhad surname: Zamani fullname: Zamani, Farhad email: Zamani.Farhad@gmail.com organization: Gastroenterology and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Beh Afarin St., Karim Khan Zand Ave., 15900, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26718936$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUl2LEzEUHWTF_dC_sAR88WVqkk4-RkQsRd3iSvFjwbeQyWTc1EwyJpmF_o79w5u2W4Q-WJ8SknPOvffcc16cOO90UVwiOEEQ0deryao1Uvl-mGCIyAShCUT1k-IMcTYtKwp_nuQ7JLTkDLPT4jzGFYSQEoKeFaeYMsTrKT0r7pdDMr20QI3Jdx0YvHEpgs4HcLX8MisX34B0Lfh6s5h_XgDjQLrVIFf-5Xw0EfgO9DrJxlujQFy7Nvhebxm531Ja5W-3X51MaQ2sudMhs6OWUb8Bs1xtGK1MxjvQ5KcWxDS26-fF007aqF88nhfFzccPP-ZX5fXy02I-uy4VhSSVqOkw4ZA3VZ5ESdnKCjc1o1NWM84h5o3qKk4qifi0hrhhHdOsIUghVMMG0-lF8WqnOwT_Z9Qxid5Epa2VTvsxCsQxqzGsSHUcyiiDjLMt9OUBdOXH4PIgGxQlNa5YnVGXj6ix6XUrhpC3ENZiv5kMeLsDqOBjDLoTyqStVSlIYwWCYhMEsRL7IIhNEARCIgch0-kBfV_hKPH9jqiz83dGBxGV0U7p1gStkmi9OS7x7kBCWeOMkva3Xuv41w4RsYDi-yamm5QiArPZDP9b4H86eAArmfnj |
CitedBy_id | crossref_primary_10_25048_tudod_1461623 crossref_primary_10_4093_jkd_2021_22_3_207 crossref_primary_10_1038_s41598_022_27269_6 crossref_primary_10_1016_j_carbpol_2017_08_071 crossref_primary_10_1038_s41598_024_81551_3 crossref_primary_10_1002_edm2_70006 crossref_primary_10_1016_j_numecd_2023_08_020 crossref_primary_10_3390_ijms23020786 crossref_primary_10_1210_clinem_dgaa265 crossref_primary_10_3389_fpubh_2022_1006332 crossref_primary_10_1002_ptr_6487 crossref_primary_10_3389_fendo_2024_1329380 crossref_primary_10_1080_00015385_2017_1410335 crossref_primary_10_1089_jmf_2022_K_0019 crossref_primary_10_1371_journal_pone_0165689 crossref_primary_10_3390_ijerph182010986 crossref_primary_10_1136_bmjopen_2018_025674 crossref_primary_10_7570_jomes21093 crossref_primary_10_1016_j_tjog_2020_09_014 crossref_primary_10_1007_s00125_017_4340_1 crossref_primary_10_12677_ACM_2023_13102233 crossref_primary_10_1371_journal_pone_0317607 crossref_primary_10_1039_C8FO01323C crossref_primary_10_1016_j_nut_2019_01_008 crossref_primary_10_1161_STROKEAHA_116_014097 crossref_primary_10_1016_j_atherosclerosis_2024_117508 crossref_primary_10_7570_jomes21065 crossref_primary_10_4103_jss_jss_346_23 crossref_primary_10_12688_f1000research_106723_2 crossref_primary_10_1016_j_jacl_2016_02_013 crossref_primary_10_12688_f1000research_106723_1 crossref_primary_10_1002_oby_22276 crossref_primary_10_1055_a_1831_0265 crossref_primary_10_3389_fnut_2023_1155436 crossref_primary_10_7759_cureus_50524 crossref_primary_10_1111_jch_14600 crossref_primary_10_1186_s12944_017_0618_z crossref_primary_10_36106_2801124 crossref_primary_10_3390_nu16091381 crossref_primary_10_1186_s13104_018_3212_1 crossref_primary_10_1016_j_ypmed_2017_11_007 crossref_primary_10_1016_j_tmsr_2018_04_001 crossref_primary_10_3803_EnM_2021_1110 crossref_primary_10_4103_ijnmr_ijnmr_451_20 crossref_primary_10_1136_bmjopen_2018_026337 crossref_primary_10_15171_mejdd_2017_56 crossref_primary_10_1007_s40200_023_01347_6 crossref_primary_10_1177_11795514231168279 crossref_primary_10_1186_s12944_020_01410_8 crossref_primary_10_1002_oby_23438 crossref_primary_10_1038_s41598_020_67238_5 crossref_primary_10_5812_hepatmon_102972 |
Cites_doi | 10.1002/hep.25539 10.3390/nu5051544 10.1126/science.1204265 10.1186/1472-6823-13-47 10.4274/Jcrpe.1127 10.1038/nrm1837 10.1053/j.gastro.2012.02.003 10.1053/gast.2001.23256 10.1001/jama.287.3.356 10.1590/S0004-28032010000200009 10.2337/dc08-1800 10.1210/jcem.87.1.8292 10.1038/sj.jhh.1002201 10.1016/S0140-6736(05)66378-7 10.1016/j.cmet.2012.03.005 10.1038/nrm2327 10.2337/diabetes.54.7.1914 10.1111/j.1365-2036.2010.04556.x 10.1016/S0140-6736(95)92143-5 10.1056/NEJM199312303292703 10.1007/BF00280883 10.4239/wjd.v1.i2.36 10.1001/jama.283.2.221 10.1002/hep.23280 10.2337/diab.37.12.1595 |
ContentType | Journal Article |
Copyright | 2016 Elsevier Inc. Elsevier Inc. Copyright © 2016 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Mar 2016 |
Copyright_xml | – notice: 2016 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2016 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Mar 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BENPR CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH K6X K9- K9. KB0 M0R M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 7T5 H94 |
DOI | 10.1016/j.jdiacomp.2015.11.019 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & allied health premium. Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest British Nursing Database British Nursing Index ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE MEDLINE - Academic Research Library Prep AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-460X |
EndPage | 274 |
ExternalDocumentID | 3957640391 26718936 10_1016_j_jdiacomp_2015_11_019 S1056872715004572 1_s2_0_S1056872715004572 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABGSF ABJNI ABMAC ABMZM ABUDA ABUWG ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKRA AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKNYI BKOJK BLXMC BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 D-I DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HDZ HMCUK HMK HMO HVGLF HZ~ IHE J1W K-O K9- KOM L7B LZ1 M0R M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ SV3 T5K UKHRP WOW WUQ Z5R ~G- 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX ACLOT CITATION ~HD CGR CUY CVF ECM EIF NPM 7XB 8FK AGRNS ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c605t-1bf25808b4936caada42b976379788028bcf4854a183902b7f7e7b51c1190b263 |
IEDL.DBID | 7X7 |
ISSN | 1056-8727 1873-460X |
IngestDate | Sun Sep 28 10:17:50 EDT 2025 Sat Sep 27 21:28:45 EDT 2025 Sat Jul 26 02:26:50 EDT 2025 Wed Feb 19 02:00:29 EST 2025 Wed Oct 01 01:28:40 EDT 2025 Thu Apr 24 23:06:27 EDT 2025 Fri Feb 23 02:24:52 EST 2024 Sun Feb 23 10:19:08 EST 2025 Tue Aug 26 16:31:53 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Homeostatic model assessment index Metabolic syndrome Non-alcoholic fatty liver disease Diagnostic index Quantitative insulin sensitivity check index |
Language | English |
License | Copyright © 2016 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c605t-1bf25808b4936caada42b976379788028bcf4854a183902b7f7e7b51c1190b263 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 26718936 |
PQID | 1766592479 |
PQPubID | 1226340 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1827920454 proquest_miscellaneous_1767078754 proquest_journals_1766592479 pubmed_primary_26718936 crossref_citationtrail_10_1016_j_jdiacomp_2015_11_019 crossref_primary_10_1016_j_jdiacomp_2015_11_019 elsevier_sciencedirect_doi_10_1016_j_jdiacomp_2015_11_019 elsevier_clinicalkeyesjournals_1_s2_0_S1056872715004572 elsevier_clinicalkey_doi_10_1016_j_jdiacomp_2015_11_019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-03-01 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Philadelphia |
PublicationTitle | Journal of diabetes and its complications |
PublicationTitleAlternate | J Diabetes Complications |
PublicationYear | 2016 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Zamani, Sohrabi, Alipour, Motamed, Saeedian, Pirzad, Khonsari (bb0085) 2014; 17 Ford, Giles, Dietz (bb0045) 2002; 287 Chen, Sullivan, Quon (bb0140) 2005; 54 Cusi (bb0125) 2012; 142 Gayoso-Diz, Otero-Gonzalez, Rodriguez-Alvarez, Gude, Garcia, De Francisco, Quintela (bb0105) 2013; 13 Singh, Garg, Tandon, Marwaha (bb0110) 2013; 5 Jornayvaz, Shulman (bb0120) 2012; 15 Salgado, Carvalho, Oliveira, Santos, Vieira, Parise (bb0115) 2010; 47 Dowman, Tomlinson, Newsome (bb0100) 2011; 33 Muoio, Newgard (bb0010) 2008; 9 Singh, Saxena (bb0075) 2010; 1 Fabbrini, Sullivan, Klein (bb0060) 2010; 51 Gaggini, Morelli, Buzzigoli, DeFronzo, Bugianesi, Gastaldelli (bb0135) 2013; 5 Eckel, Grundy, Zimmet (bb0040) 2005; 365 Motamed, Razmjou, Hemmasi, Maadi, Zamani (bb0090) 2015 Lomonaco, Ortiz-Lopez, Orsak, Webb, Hardies, Darland, Cusi (bb0130) 2012; 55 Duncan, Singh, Wise, Carter, Alaghband-Zadeh (bb0070) 1995; 346 Meigs, Mittleman, Nathan, Tofler, Singer, Murphy-Sheehy, Wilson (bb0015) 2000; 283 Cohen, Horton, Hobbs (bb0055) 2011; 332 Taniguchi, Emanuelli, Kahn (bb0005) 2006; 7 Lillioja, Mott, Spraul, Ferraro, Foley, Ravussin, Bogardus (bb0020) 1993; 329 Sarafidis, Lasaridis, Nilsson, Pikilidou, Stafilas, Kanaki, Bakris (bb0145) 2007; 21 Sanyal, Campbell-Sargent, Mirshahi, Rizzo, Contos, Sterling, Clore (bb0025) 2001; 120 Hrebicek, Janout, Malincikova, Horakova, Cizek (bb0080) 2002; 87 Argiles, Lopez-Soriano (bb0030) 2001; 18 Delavari, Forouzanfar, Alikhani, Sharifian, Kelishadi (bb0095) 2009; 32 Reaven (bb0035) 1988; 37 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0065) 1985; 28 Hajian-Tilaki (bb0050) 2015; 6 Reaven (10.1016/j.jdiacomp.2015.11.019_bb0035) 1988; 37 Matthews (10.1016/j.jdiacomp.2015.11.019_bb0065) 1985; 28 Lillioja (10.1016/j.jdiacomp.2015.11.019_bb0020) 1993; 329 Argiles (10.1016/j.jdiacomp.2015.11.019_bb0030) 2001; 18 Gaggini (10.1016/j.jdiacomp.2015.11.019_bb0135) 2013; 5 Cusi (10.1016/j.jdiacomp.2015.11.019_bb0125) 2012; 142 Dowman (10.1016/j.jdiacomp.2015.11.019_bb0100) 2011; 33 Muoio (10.1016/j.jdiacomp.2015.11.019_bb0010) 2008; 9 Sarafidis (10.1016/j.jdiacomp.2015.11.019_bb0145) 2007; 21 Taniguchi (10.1016/j.jdiacomp.2015.11.019_bb0005) 2006; 7 Hajian-Tilaki (10.1016/j.jdiacomp.2015.11.019_bb0050) 2015; 6 Ford (10.1016/j.jdiacomp.2015.11.019_bb0045) 2002; 287 Delavari (10.1016/j.jdiacomp.2015.11.019_bb0095) 2009; 32 Hrebicek (10.1016/j.jdiacomp.2015.11.019_bb0080) 2002; 87 Sanyal (10.1016/j.jdiacomp.2015.11.019_bb0025) 2001; 120 Jornayvaz (10.1016/j.jdiacomp.2015.11.019_bb0120) 2012; 15 Motamed (10.1016/j.jdiacomp.2015.11.019_bb0090) 2015 Meigs (10.1016/j.jdiacomp.2015.11.019_bb0015) 2000; 283 Cohen (10.1016/j.jdiacomp.2015.11.019_bb0055) 2011; 332 Eckel (10.1016/j.jdiacomp.2015.11.019_bb0040) 2005; 365 Lomonaco (10.1016/j.jdiacomp.2015.11.019_bb0130) 2012; 55 Fabbrini (10.1016/j.jdiacomp.2015.11.019_bb0060) 2010; 51 Singh (10.1016/j.jdiacomp.2015.11.019_bb0075) 2010; 1 Salgado (10.1016/j.jdiacomp.2015.11.019_bb0115) 2010; 47 Zamani (10.1016/j.jdiacomp.2015.11.019_bb0085) 2014; 17 Duncan (10.1016/j.jdiacomp.2015.11.019_bb0070) 1995; 346 Gayoso-Diz (10.1016/j.jdiacomp.2015.11.019_bb0105) 2013; 13 Chen (10.1016/j.jdiacomp.2015.11.019_bb0140) 2005; 54 Singh (10.1016/j.jdiacomp.2015.11.019_bb0110) 2013; 5 |
References_xml | – volume: 332 start-page: 1519 year: 2011 end-page: 1523 ident: bb0055 article-title: Human fatty liver disease: Old questions and new insights publication-title: Science – volume: 54 start-page: 1914 year: 2005 end-page: 1925 ident: bb0140 article-title: Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model publication-title: Diabetes – volume: 33 start-page: 525 year: 2011 end-page: 540 ident: bb0100 article-title: Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis publication-title: Alimentary Pharmacology & Therapeutics – volume: 346 start-page: 120 year: 1995 end-page: 121 ident: bb0070 article-title: A simple measure of insulin resistance publication-title: Lancet – volume: 13 start-page: 47 year: 2013 ident: bb0105 article-title: Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study publication-title: BMC Endocrine Disorders – volume: 120 start-page: 1183 year: 2001 end-page: 1192 ident: bb0025 article-title: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities publication-title: Gastroenterology – volume: 32 start-page: 1092 year: 2009 end-page: 1097 ident: bb0095 article-title: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran publication-title: Diabetes Care – volume: 37 start-page: 1595 year: 1988 end-page: 1607 ident: bb0035 article-title: Banting lecture 1988. Role of insulin resistance in human disease publication-title: Diabetes – volume: 15 start-page: 574 year: 2012 end-page: 584 ident: bb0120 article-title: Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance publication-title: Cell Metabolism – volume: 21 start-page: 709 year: 2007 end-page: 716 ident: bb0145 article-title: Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type 2 diabetes publication-title: Journal of Human Hypertension – volume: 6 start-page: 51 year: 2015 end-page: 61 ident: bb0050 article-title: Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review publication-title: Caspian journal of internal medicine – volume: 9 start-page: 193 year: 2008 end-page: 205 ident: bb0010 article-title: Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes publication-title: Nature Reviews Molecular Cell Biology – volume: 5 start-page: 245 year: 2013 end-page: 251 ident: bb0110 article-title: A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents publication-title: Journal of Clinical Research in Pediatric Endocrinology – volume: 7 start-page: 85 year: 2006 end-page: 96 ident: bb0005 article-title: Critical nodes in signalling pathways: Insights into insulin action publication-title: Nature Reviews Molecular Cell Biology – volume: 142 start-page: 711 year: 2012 end-page: 725 ident: bb0125 article-title: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications publication-title: Gastroenterology – volume: 329 start-page: 1988 year: 1993 end-page: 1992 ident: bb0020 article-title: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus publication-title: Prospective studies of Pima Indians, The New England Journal of Medicine – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: bb0065 article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 5 start-page: 1544 year: 2013 end-page: 1560 ident: bb0135 article-title: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease publication-title: Nutrients – volume: 365 start-page: 1415 year: 2005 end-page: 1428 ident: bb0040 article-title: The metabolic syndrome publication-title: Lancet – volume: 18 start-page: 683 year: 2001 end-page: 687 ident: bb0030 article-title: Insulin and cancer (review) publication-title: International Journal of Oncology – volume: 55 start-page: 1389 year: 2012 end-page: 1397 ident: bb0130 article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease publication-title: Hepatology – volume: 17 start-page: 750 year: 2014 end-page: 754 ident: bb0085 article-title: Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: A population based study publication-title: Archives of Iranian Medicine – volume: 47 start-page: 165 year: 2010 end-page: 169 ident: bb0115 article-title: Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals publication-title: Arquivos de Gastroenterologia – volume: 51 start-page: 679 year: 2010 end-page: 689 ident: bb0060 article-title: Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications publication-title: Hepatology – year: 2015 ident: bb0090 article-title: Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol publication-title: Journal of Endocrinological Investigation – volume: 287 start-page: 356 year: 2002 end-page: 359 ident: bb0045 article-title: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey publication-title: JAMA: the journal of the American Medical Association – volume: 1 start-page: 36 year: 2010 end-page: 47 ident: bb0075 article-title: Surrogate markers of insulin resistance: A review publication-title: World journal of diabetes – volume: 283 start-page: 221 year: 2000 end-page: 228 ident: bb0015 article-title: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study publication-title: JAMA: the journal of the American Medical Association – volume: 87 start-page: 144 year: 2002 end-page: 147 ident: bb0080 article-title: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention publication-title: The Journal of Clinical Endocrinology and Metabolism – volume: 55 start-page: 1389 issue: 5 year: 2012 ident: 10.1016/j.jdiacomp.2015.11.019_bb0130 article-title: Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.25539 – volume: 17 start-page: 750 issue: 11 year: 2014 ident: 10.1016/j.jdiacomp.2015.11.019_bb0085 article-title: Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: A population based study publication-title: Archives of Iranian Medicine – volume: 5 start-page: 1544 issue: 5 year: 2013 ident: 10.1016/j.jdiacomp.2015.11.019_bb0135 article-title: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease publication-title: Nutrients doi: 10.3390/nu5051544 – volume: 332 start-page: 1519 issue: 6037 year: 2011 ident: 10.1016/j.jdiacomp.2015.11.019_bb0055 article-title: Human fatty liver disease: Old questions and new insights publication-title: Science doi: 10.1126/science.1204265 – volume: 13 start-page: 47 year: 2013 ident: 10.1016/j.jdiacomp.2015.11.019_bb0105 article-title: Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study publication-title: BMC Endocrine Disorders doi: 10.1186/1472-6823-13-47 – volume: 5 start-page: 245 issue: 4 year: 2013 ident: 10.1016/j.jdiacomp.2015.11.019_bb0110 article-title: A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents publication-title: Journal of Clinical Research in Pediatric Endocrinology doi: 10.4274/Jcrpe.1127 – volume: 7 start-page: 85 issue: 2 year: 2006 ident: 10.1016/j.jdiacomp.2015.11.019_bb0005 article-title: Critical nodes in signalling pathways: Insights into insulin action publication-title: Nature Reviews Molecular Cell Biology doi: 10.1038/nrm1837 – volume: 142 start-page: 711 issue: 4 year: 2012 ident: 10.1016/j.jdiacomp.2015.11.019_bb0125 article-title: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.02.003 – volume: 120 start-page: 1183 issue: 5 year: 2001 ident: 10.1016/j.jdiacomp.2015.11.019_bb0025 article-title: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities publication-title: Gastroenterology doi: 10.1053/gast.2001.23256 – volume: 18 start-page: 683 issue: 4 year: 2001 ident: 10.1016/j.jdiacomp.2015.11.019_bb0030 article-title: Insulin and cancer (review) publication-title: International Journal of Oncology – volume: 287 start-page: 356 issue: 3 year: 2002 ident: 10.1016/j.jdiacomp.2015.11.019_bb0045 article-title: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey publication-title: JAMA: the journal of the American Medical Association doi: 10.1001/jama.287.3.356 – volume: 47 start-page: 165 issue: 2 year: 2010 ident: 10.1016/j.jdiacomp.2015.11.019_bb0115 article-title: Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals publication-title: Arquivos de Gastroenterologia doi: 10.1590/S0004-28032010000200009 – volume: 32 start-page: 1092 issue: 6 year: 2009 ident: 10.1016/j.jdiacomp.2015.11.019_bb0095 article-title: First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran publication-title: Diabetes Care doi: 10.2337/dc08-1800 – volume: 87 start-page: 144 issue: 1 year: 2002 ident: 10.1016/j.jdiacomp.2015.11.019_bb0080 article-title: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention publication-title: The Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jcem.87.1.8292 – volume: 21 start-page: 709 issue: 9 year: 2007 ident: 10.1016/j.jdiacomp.2015.11.019_bb0145 article-title: Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type 2 diabetes publication-title: Journal of Human Hypertension doi: 10.1038/sj.jhh.1002201 – volume: 365 start-page: 1415 issue: 9468 year: 2005 ident: 10.1016/j.jdiacomp.2015.11.019_bb0040 article-title: The metabolic syndrome publication-title: Lancet doi: 10.1016/S0140-6736(05)66378-7 – volume: 15 start-page: 574 issue: 5 year: 2012 ident: 10.1016/j.jdiacomp.2015.11.019_bb0120 article-title: Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance publication-title: Cell Metabolism doi: 10.1016/j.cmet.2012.03.005 – volume: 9 start-page: 193 issue: 3 year: 2008 ident: 10.1016/j.jdiacomp.2015.11.019_bb0010 article-title: Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes publication-title: Nature Reviews Molecular Cell Biology doi: 10.1038/nrm2327 – volume: 54 start-page: 1914 issue: 7 year: 2005 ident: 10.1016/j.jdiacomp.2015.11.019_bb0140 article-title: Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model publication-title: Diabetes doi: 10.2337/diabetes.54.7.1914 – volume: 6 start-page: 51 issue: 2 year: 2015 ident: 10.1016/j.jdiacomp.2015.11.019_bb0050 article-title: Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review publication-title: Caspian journal of internal medicine – volume: 33 start-page: 525 issue: 5 year: 2011 ident: 10.1016/j.jdiacomp.2015.11.019_bb0100 article-title: Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis publication-title: Alimentary Pharmacology & Therapeutics doi: 10.1111/j.1365-2036.2010.04556.x – volume: 346 start-page: 120 issue: 8967 year: 1995 ident: 10.1016/j.jdiacomp.2015.11.019_bb0070 article-title: A simple measure of insulin resistance publication-title: Lancet doi: 10.1016/S0140-6736(95)92143-5 – volume: 329 start-page: 1988 issue: 27 year: 1993 ident: 10.1016/j.jdiacomp.2015.11.019_bb0020 article-title: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus publication-title: Prospective studies of Pima Indians, The New England Journal of Medicine doi: 10.1056/NEJM199312303292703 – volume: 28 start-page: 412 issue: 7 year: 1985 ident: 10.1016/j.jdiacomp.2015.11.019_bb0065 article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 1 start-page: 36 issue: 2 year: 2010 ident: 10.1016/j.jdiacomp.2015.11.019_bb0075 article-title: Surrogate markers of insulin resistance: A review publication-title: World journal of diabetes doi: 10.4239/wjd.v1.i2.36 – volume: 283 start-page: 221 issue: 2 year: 2000 ident: 10.1016/j.jdiacomp.2015.11.019_bb0015 article-title: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study publication-title: JAMA: the journal of the American Medical Association doi: 10.1001/jama.283.2.221 – volume: 51 start-page: 679 issue: 2 year: 2010 ident: 10.1016/j.jdiacomp.2015.11.019_bb0060 article-title: Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications publication-title: Hepatology doi: 10.1002/hep.23280 – volume: 37 start-page: 1595 issue: 12 year: 1988 ident: 10.1016/j.jdiacomp.2015.11.019_bb0035 article-title: Banting lecture 1988. Role of insulin resistance in human disease publication-title: Diabetes doi: 10.2337/diab.37.12.1595 – year: 2015 ident: 10.1016/j.jdiacomp.2015.11.019_bb0090 article-title: Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol publication-title: Journal of Endocrinological Investigation |
SSID | ssj0006551 |
Score | 2.3446655 |
Snippet | The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity check... Abstract Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin... Aims The present study was carried out to determine the optimal cutoff points for homeostatic model assessment (HOMA-IR) and quantitative insulin sensitivity... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 269 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Child Cohort Studies Diagnostic index Diagnostic Techniques, Endocrine - standards Endocrinology & Metabolism Female Homeostatic model assessment index Humans Insulin Insulin Resistance Liver Male Metabolic syndrome Metabolic Syndrome - diagnosis Metabolic Syndrome - metabolism Middle Aged Non-alcoholic fatty liver disease Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - metabolism Quantitative insulin sensitivity check index Reference Values ROC Curve Sensitivity and Specificity Studies Young Adult |
SummonAdditionalLinks | – databaseName: Elsevier ScienceDirect dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Li9swEBbLHpZeSrfPbLdFhV6VOIpk2XsLYZekJV36COxNSLYEDlk71M5hL_0T_cM7Y8vZlj5pLwZbIyQ045lPaPQNIa8jl1vHU8fExMfw4JZZE3nmRYrs6hA12luuy3fxfCXeXMmrAzLr78JgWmXw_Z1Pb711-DIKqznaFsXoI9aMTyD8AqQBXKLQDyP7F9j08Mtdmkcs2xKMKMxQ-ptbwuvhGnSAqduY4iWHyOaJjDs_D1C_AqBtILp4QO4HBEmn3SSPyYErH5KjZTgjf0S-XoIXuAaJbNdU3tNtVZRNTQGc0vnlcsoWH6gpc_p-tZi9XdCipAABad5l3BU1rTy9dg2YxqbIaM9n0PYoq5KZrqIuNHnTNDd0g2kdNJzynNEpjNYXBKMYIHPa8tc-JquL80-zOQulF1gG-5uGja3nMokSK9JJnBmTG8EtIJeJgl1nApjEZl4kUhgEWBG3yiunrBxnYwAYFvT7hBzCrNwzQhMvDAfXAFsRI5RPLCBE7uREpIDrAc0MiOzXW2eBlxzLY2x0n4C21r2eNOoJNi0a9DQgo32_bcfM8cceqlen7u-dgqfUEDz-raerww9f67GuuY70D0Y5IOm-53d2_VejnvY2p-8GUjGehAsFza_2zeAT8KDHlK7atTJI4qSk-I1MgtSRSMA4IE87e94vI48BsYDiT_5j8s_JPXiLu3S9U3LYfN65F4DfGvuy_UFvAaptQU4 priority: 102 providerName: Elsevier |
Title | Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1056872715004572 https://www.clinicalkey.es/playcontent/1-s2.0-S1056872715004572 https://dx.doi.org/10.1016/j.jdiacomp.2015.11.019 https://www.ncbi.nlm.nih.gov/pubmed/26718936 https://www.proquest.com/docview/1766592479 https://www.proquest.com/docview/1767078754 https://www.proquest.com/docview/1827920454 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1873-460X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1873-460X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1873-460X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1873-460X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-460X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: AKRWK dateStart: 19920101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1873-460X dateEnd: 20250801 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: 7X7 dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1873-460X dateEnd: 20250801 omitProxy: true ssIdentifier: ssj0006551 issn: 1056-8727 databaseCode: BENPR dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbYJiEuiPEzsFVG4poucZ044YLKtKllageDSr1ZdmJLrbqkkPTAhX-Cf5j3Eidw2Abikhxiy5bf83vfi5-_R8ibwOTasNT4fGRjeDDtaxVY3_IU2dXBazS3XGfzeLLgH5bR0v1wq1xaZWcTG0Odlxn-Iz9BIsMIggWRvtt-9bFqFJ6uuhIae-QgBKiCWi2WfcAF3rUpv4jF5WHXM_HHDeH1cA3rj2nbmN4VDZHJE9l2bnZOt4HPxgmdPyIPHXqk41bch-SeKR6T-zN3Pv6E_LwEC3ANLbJdXVpLt-WqqCsKwJROLmdjf3pFVZHTT4vp6cWUrgoK8I_mbbbdqqKlpdemBrXYrDLacRk0PYqy8FVbTRc-WVXX3-kGUzqoO-F5S8cwWlcMjKJzzGnDXfuULM7PvpxOfFd2wc8gtqn9UFsWJUGieTqKM6VyxZkG1DISEHEmgEd0ZnkScYXgKmBaWGGEjsIMRBBokO0zsg-zMi8ITSxXDMwChCGKC5toQIfMRCOeAqYHJOORqFtvmTlOciyNsZFd8tladnKSKCcIWCTIySMnfb9ty8rx1x6iE6fs7pyClZTgOP6vp6ncZq9kKCsmA_kZ9QzVDDA2AGXBPJL2PR2eaXHKP4161Omc_D1Qvwc88rr_DPYAD3lUYcpd0wYJnETE72iTIG0kki965Hmrz_0yshjQCgj-5d0TeEUewGzjNhvviOzX33bmGOBZrQdkb_gjHDQ7cUAOxtOLyRze78_mH69-ASteOxM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8CA4wEj9lSx4kTJISqwdTSdROwSn3z7MSWWnVJIanQPgffg8_IXRIHHmAgpL3kJb7Yyl3ufheff0fIi8Dk2rDU-Dy0MVyY9rUKrG95iuzqEDWaU67To3g04-_n0XyLfHdnYbCs0vnExlHnZYb_yPeQyDCCZEGkb9affewahburroVGaxYTc_4VUrbq9fgt6PclYwfvTvZHftdVwM8Autf-QFsWJUGieRrGmVK54kxDUA4FJFQJhFudWZ5EXCF2CJgWVhiho0E2gNipYenw3CvkKg8Djlz9Yt4neBDNm3aP2MwevAwTv5xIXu4uQd9YJo7lZNEuMociu8_vg-GfwG4T9A5ukZsdWqXD1rxuky1T3CHXpt1-_F3y7Rg8zhmMyDZ1aS1dl4uirigAYTo6ng798Ueqipx-mI33J2O6KCjATZq31X2LipaWnpkazHC1yKjjTmgkirLwVdu9F25ZVdfndIUlJLTbUXpFhzCbaz5GMRjntOHKvUdml6KQ-2QbVmUeEppYrhi4IUh7FBc20YBGmYlCnkIOAcjJI5F73zLrONCxFcdKumK3pXR6kqgnSJAk6Mkje73cumUB-auEcOqU7owreGUJger_JE3VOZdKDmTFZCA_oZ2hmQGmB2AumEfSXrLDTy0u-qdZd5zNyZ8T9d-cR573t8H_4KaSKky5acYgYZSI-AVjEqSpRLJHjzxo7bl_jSwGdASKf3TxAp6R66OT6aE8HB9NHpMbsPK4rQTcIdv1l415AtCw1k-b75GS08t2AD8AFblxvw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEP8JDDASPGZtHSdOkBCqNqqW0o1_lfrm2YktteqSQlKhfQ6-DZ-OuyQOPMBASHvpS3y1mzvf_a4-_46QZ32TacMS4_PARvDBtK9V3_qWJ8iuDlGjvuU6O47Gc_5mES52yHd3FwbLKp1PrB11VqT4H3kPiQxDSBZE0rNtWcS7o9GrzWcfO0jhSatrp9GYyNScf4X0rXw5OQJdP2ds9PrT4dhvOwz4KcD4yh9oy8K4H2ueBFGqVKY40xCgAwHJVQyhV6eWxyFXiCP6TAsrjNDhIB1AHNXwM-B7r5CrIuABlpOJRZfsQWSvWz9iY3vwOEz8cjt5dbAC3WPJOJaWhQfIIopMP78PjH8CvnUAHN0g11vkSoeNqd0kOya_RfZm7dn8bfLtBLzPGYxIt1VhLd0Uy7wqKYBiOj6ZDf3JB6ryjL6fTw6nE7rMKUBPmjWVfsuSFpaemQpMcr1MqeNRqCXyIvdV08kXHllVVed0jeUktD1dekGHMJtrREYxMGe05s29Q-aXopC7ZBdWZe4TGluuGLgkSIEUFzbWgEyZCQOeQD4BKMojoXvfMm350LEtx1q6wreVdHqSqCdIliToySO9Tm7TMIL8VUI4dUp33xU8tISg9X-SpmwdTSkHsmSyLz-inaGZAb4HkC6YR5JOssVSDUb6p1n3nc3JnxN1-88jT7vH4IvwgEnlptjWY5A8SoT8gjExUlYi8aNH7jX23L1GFgFSAsU_uHgBT8gebH35dnI8fUiuwcKjpihwn-xWX7bmEaDESj-utyMlp5e9_38AsRR1-g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+cutoff+points+for+HOMA-IR+and+QUICKI+in+the+diagnosis+of+metabolic+syndrome+and+non-alcoholic+fatty+liver+disease%3A+A+population+based+study&rft.jtitle=Journal+of+diabetes+and+its+complications&rft.au=Motamed%2C+Nima&rft.au=Miresmail%2C+Seyed+Javad+Haji&rft.au=Rabiee%2C+Behnam&rft.au=Keyvani%2C+Hossein&rft.date=2016-03-01&rft.pub=Elsevier+Inc&rft.issn=1056-8727&rft.volume=30&rft.issue=2&rft.spage=269&rft.epage=274&rft_id=info:doi/10.1016%2Fj.jdiacomp.2015.11.019&rft.externalDocID=S1056872715004572 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10568727%2FS1056872716X00025%2Fcov150h.gif |